“…EDITOR, - M F Bristow and D Kohen state that the neuroleptic malignant syndrome may occur in response to the sudden cessation of dopamine agonists as well as in patients treated with neuroleptic drugs 1. But the syndrome has also been reported after the administration of non-neuroleptic drugs, including lithium, metoclopramide, carbamazepine, antidepressants (including dothiepin and amoxapine), tetrabenazine, and metirosine.…”